## Abstract We have shown recently that inhibition of androgen receptor (AR) expression with an antisense AR oligonucleotide (ODN) inhibits LNCaP prostate tumor cells in vitro as well as in vivo. In this study, we investigated gene expression changes that occur after AR signaling blockade, either t
Coprinus comatusandGanoderma luciduminterfere with androgen receptor function in LNCaP prostate cancer cells
✍ Scribed by Ben-Zion Zaidman; Solomon P. Wasser; Eviatar Nevo; Jamal Mahajna
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 410 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0301-4851
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We previously demonstrated that ectopic expression of neurotrophic peptide (NP) derived from saposin C promotes androgen receptor (AR) expression and transactivation in human prostate cancer cells. This prompted us to investigate how NP or saposin C can function in cells. We constructed
## Abstract To elucidate the mechanism of androgen‐dependent cellular proliferation in prostate cancer, androgen‐dependent alterations of individual cell cycle regulatory proteins in the androgen‐sensitive prostate cancer cell line LNCaP were evaluated. LNCaP cells were deprived of androgens by cul
## Abstract The molecular mechanism underlying the actions of estrogens in normal prostate physiology and prostate cancer development remains unclear. In the present study we tested the hypothesis that estrogens modulate androgen‐dependent events in prostate cells by examining the effects of 17β‐es